No significant difference seen for in-hospital mortality among those receiving remdesivir, hydroxychloroquine, standard of care
Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
WHO: Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots
Advocacy group ONE Campaign says only 1 percent of people in poor countries have received even one COVID-19 vaccine dose
Pfizer Presses U.S. Scientists, Officials on Third Booster Shot
U.S. officials say that more data are needed before regulators can determine whether booster shots are necessary